Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.
CME information and select publications here.
You May Also Like
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Deep Marine Scenes
Deep Marine Scenes
Dead Rabbit Radio The Daily Paranormal Podcast
Jason Carpenter
Eye On The Sky
Vermont Public
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Hematologic Oncology Update
Dr. Neil Love
Zvedavosť
Denník N
Sage Sociology
Sage Publications
La Science, CQFD
France Culture
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Deep Marine Scenes
Deep Marine Scenes
Dead Rabbit Radio The Daily Paranormal Podcast
Jason Carpenter
Eye On The Sky
Vermont Public
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Hematologic Oncology Update
Dr. Neil Love
Zvedavosť
Denník N
Sage Sociology
Sage Publications
La Science, CQFD
France Culture
Community discussion